NCT02333643View on ClinicalTrials.gov

A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.

PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Cutaneous Warts
Interventions
DRUG

CLS003

DRUG

Furosemide

DRUG

Digoxin

DRUG

Vehicle topical

Trial Locations (1)

Unknown

LUMC/Centre for Human Drug Research, Leiden

All Listed Sponsors
lead

Maruho Co., Ltd.

INDUSTRY

NCT02333643 - A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. | Biotech Hunter | Biotech Hunter